Biotechnology doesn’t fall neatly into any one of the 16 government-designated critical infrastructure sectors that receive specialized and focused attention from feds, leading some lawmakers to worry that it’s not getting the protection from cyberattacks and other risks that it needs.
That’s why a bipartisan group of senators and representatives announced legislation Thursday that would place an emphasis at the Cybersecurity and Infrastructure Security Agency on defending biotechnology, biomanufacturing and biological data.
The Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act and the Protecting Biological Data Act are two separate bills with the same group of cosponsors. Both bills would weave biotech into the law that established the Department of Homeland Security.
The former would direct DHS to come up with plans to make sure biotech and biomanufacturing are protected as critical infrastructure, but not as a whole new sector. The plans would identify key biotech players, conduct outreach to them and develop steps to update the National Infrastructure Protection Plan this year to incorporate biotech sector input.
The latter would make sure that systems handling genomic sequences and sensitive biometric data are covered as critical infrastructure and integrated into the national cyber strategy, that CISA would work with biotech players on security steps like joint exercises and that the agency would get new personnel to handle biometric data security.
In the last two months, biotech giants Boston Scientific and Amgen have revealed that they suffered recent cyberattacks.
Sponsors of the measures include leaders and members of the National Security Commission on Emerging Biotechnology, a legislative advisory group.
“Biotechnology infrastructure and data are becoming vital to America’s economic and national security,” said Commission Chair Senator Todd Young, R-Ind. “Just as we are serious about where the sensitive data of Americans is stored and who can access it, we should be equally serious about protecting our biological data and infrastructure. Designating biotech as critical infrastructure is about recognizing its strategic importance and making sure the capabilities America will depend on tomorrow remain resilient and protected from foreign threats.”
Notably, however, the bills do not seek a separate critical infrastructure category for biotech to add to the 16. Currently, biotech cuts across a number of existing sectors, including the health, agricultural and industrial sectors.
Some industry groups and experts have lobbied for the inclusion of new critical infrastructure sectors, such as space or artificial intelligence.
“Protecting biomanufacturing infrastructure and the most sensitive biological data of Americans is essential for our national security,” said commissioner Rep. Ro Khanna, D-Calif. “These bipartisan bills will help ensure we are protecting this sector from physical and cyber threats while keeping America as the world leader in biotechnology.”
The bill’s sponsors in the House are Khanna, Stephanie Bice, R-Okla. and Scott Peters, D-Calif., and in the Senate the sponsors are Young and Maggie Hassan, D-N.H.
You can read the text of the bills below.